Joanne Waldstreicher, M.D.,

Chief Medical Officer,

Johnson & Johnson

Joanne Waldstreicher, M.D., is Chief Medical Officer, Johnson & Johnson. In this role, Joanne has cross-sector oversight for safety of all Johnson & Johnson products worldwide. In addition, Joanne also plays a leadership role for epidemiology, internal and external partnerships and collaborations, and development of the corporate science, technology, and R&D policies, including those related to clinical trial transparency and compassionate access. Joanne also chairs the pharmaceuticals R&D Development Committee, which reviews all late stage development programs in the pharmaceutical pipeline, and is responsible for Johnson & Johnson cross enterprise clinical and regulatory operations excellence.

 

Under Joanne’s leadership in her prior role as both Chief Medical Officer of the Pharmaceutical sector and Head of Asia Pacific Medical Sciences, four legacy safety groups were integrated into one independent Global Medical Safety organization. In addition, Joanne reshaped and realigned the R&D and medical affairs groups across Asia Pacific, resulting in an industry leading drug pipeline in Japan, and the company’s first ever international drug approval from a team based in China. 

 

Prior to becoming Chief Medical Officer in the pharmaceutical sector, Joanne served as Head of Global Drug Development for the Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) CNS/Internal Medicine business unit. In this role she was responsible for late-stage development of the CNS/Internal Medicine pipeline, spanning the areas of neuroscience, cardiovascular and metabolism including Invokana®, Xarelto®, Invega Sustenna®, and Invega Trinza®. 

 

Prior to joining Johnson & Johnson in 2002, Joanne was head of the Endocrinology and Metabolism clinical research group at Merck Research Laboratories, and responsible for overseeing clinical development of Mevacor®, Zocor®, Proscar® and Propecia®, and for clinical development programs in atherosclerosis, obesity, diabetes, urology, dermatology, and oncology. During that time, she received numerous distinctions, including the Merck Research Laboratory Key Innovator Award.

 

Joanne received both the Jonas Salk and Belle Zeller scholarships from the City University of New York and graduated Summa Cum Laude from Brooklyn College, and Cum Laude from Harvard Medical School. She completed her fellowship in endocrinology and metabolism at Massachusetts General Hospital, has won numerous awards and scholarships, and has authored numerous papers and abstracts. Joanne combines broad experience in science and medicine with a passion for advancing transparency and ethics in our industry, and a dedication to patient safety.

 

 

 

Special Thanks To Our

INVESTORS

Zehavit Cohen

Howard & Elayne Levkowitz

Fred & Tami Mack

The Mitzner Family

Michael Steinhardt